Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852783 · ClinicalTrials.gov registry record · Phase 4
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
A Phase 4 study of Aneurysm, Intracranial, sponsored by Cerus Endovascular.
- Active
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT04852783: Active Phase 4 study of Aneurysm, Intracranial, sponsored by Cerus Endovascular.
NCT04852783 is a Phase 4 study of Aneurysm, Intracranial that is active but no longer recruiting, run by Cerus Endovascular. The registered enrollment target is 250 participants, above the 215-participant average among 3 other Aneurysm, Intracranial trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04852783, a Phase 4 study of Aneurysm, Intracranial, is active but no longer recruiting, sponsored by Cerus Endovascular.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
Primary Outcome
Death or stroke within 30 days of treatment or ipsilateral stroke or neurological death between 30 days and 1 year.
Conditions Studied
Interventions
- DEVICE Contour Neurovascular System
Study Locations (20)
New York
- University at Buffalo Neurosurgery - Buffalo
- NYU Langone Health - New York
- Stony Brook Medicine - Stony Brook
- Montefiore Medical Center - The Bronx
- Westchester Medical Center - Valhalla
Pennsylvania
- The Hospital of the University of Pennsylvania - Philadelphia
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Illinois
- University of Chicago - Chicago
- Advocate Aurora Health - Park Ridge
Massachusetts
- Massachusetts General Hospital - Boston
- UMASS Medical Center - Worcester
Colorado
- Swedish Medical Center - Englewood
Florida
- Baptist Health - Jacksonville
Kansas
- University of Kansas Medical Center - Kansas City
North Carolina
- NC Heart and Vascular Research LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2030-02 |
| Phase | Phase 4 |
What the registry record for NCT04852783 still lists
NCT04852783 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 215-participant average among 3 other Aneurysm, Intracranial trials with a reported enrollment target (16% higher).
The record links to 1 condition, with Aneurysm, Intracranial appearing as the primary indexed condition, and to 1 intervention - of which Contour Neurovascular System is the first listed.
NCT04852783 names 20 study sites across 12 states, led by New York, Pennsylvania, Illinois.
Frequently Asked Questions
What is clinical trial NCT04852783 about?
NCT04852783 is a clinical study titled "US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair". The purpose of this trial is to gather data on the safety and effectiveness of the Contour /Contour 021 System in the treatment of wide-necked bifurcated saccular, intracranial aneurysms for submission to FDA in support of a premarket approval application for the device.
What is the current status of trial NCT04852783?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2021-08-06. Estimated completion is 2030-02.
What conditions does trial NCT04852783 study?
This clinical trial studies the following conditions: Aneurysm, Intracranial.
What interventions are being tested in trial NCT04852783?
The interventions under investigation include: Contour Neurovascular System (DEVICE).
Who is sponsoring clinical trial NCT04852783?
This trial is sponsored by Cerus Endovascular, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04852783 being conducted?
This trial has 20 study locations across Colorado, Florida, Illinois, Kansas, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm, Intracranial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
RECRUITING · NA
-
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
RECRUITING · NA
-
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI